top of page
Case Studies & Blogs
EU JCA is here. Rare diseases are next. Your RWD strategy can’t wait.
EU JCA will include rare diseases from 2028. Target trial framework provides a path to incorporating real world data into strategic thinking in preparation for EU JCA inclusion.
4 days ago3 min read
Real-world evidence needs real-world discipline: the FDA raises the bar
FDA issued a new guidance for medical devices and RWE. Applicability extends to drug development, regardless of the focus.
Jan 135 min read
Adigens Health is growing: Come and join us!
Senior Manager in Epidemiology based in Ireland - opportunity of a lifetime to join a unique research organisation
Jan 82 min read
bottom of page